ADCC is tightly regulated through various mechanisms to prevent excessive tissue damage. Regulatory proteins such as cytokines (e.g., IFN-γ and IL-2) can enhance ADCC by activating effector cells. Conversely, regulatory T cells and inhibitory receptors (e.g., PD-1 on NK cells) can downregulate the activity to maintain immune homeostasis.
